Recently, the p53 homolog p63 has been implicated in sustaining the epidermal stem cell population. The p63 gene encodes six major products with transactivating or dominant-negative properties. The expression pattern of these isoforms in keratinocytes was investigated here. Northern blot, ribonuclease protection assay, reverse transcription±polymerase chain reaction, and western blot techniques sensitive for all six p63 isotypes veri®ed the predominant expression of the truncated and potentially dominant-negative isotype DNp63a in human keratinocytes. The expression of this isoform is downregulated when proliferating human primary keratinocytes begin to differentiate after growth factor withdrawal. The onset of differentiation does not change the ratio of two other weakly expressed isotypes DNp63g and TAp63a relative to DNp63a. Treatment of primary human keratinocytes with all-trans retinoic acid does not alter the expression pattern of p63 isotypes but prevents its downregulation as observed in control cell cultures. These data suggest that p63 expression in human keratinocytes is affected by all-trans retinoic acid and this in¯uence might contribute to the ®ne tuned keratinocyte proliferation and differentiation equilibrium in the mammalian epidermis. Key words: involucrin/p53 protein family/p63 splice variants. J Invest Dermatol 118: 133±138, 2002 p 63 shows remarkable structural homology to the related protein p73 and the tumor suppressor p53 Strano et al, 2001 ). Whereas only a single isoform of p53 is known, multiple p63 and p73 transcripts are observed. At least two promoters exist in the p63 gene, yielding transactivating (TA, transactivation domain) as well as transactivating (DN, n-terminally truncated) isotypes. A conserved DNA binding domain and a basic tetramerization domain are present in all p63 isotypes. In conjunction with the three different carboxy-termini, a, b, and g, six major p63 isoforms are possible. For clari®cation, a full length cDNA or protein is described by its speci®c start point (TA or DN) followed by the gene name (p63) and the speci®c endpoint (a, b, or g). The gene name followed by one speci®c isoform attribute refers exclusively to this isoform irrespective of other possible isoforms at the alternative end. TAp63g resembles most p53, whereas the p63a and p63b splice variants extend the p63 protein sequence considerably. The full length p63a protein contains a sterile a motif-like sequence and a negatively charged C-terminus. As a result of exon 13 deletion, only the N-terminal part of the sterile a motif-protein domain is expressed in the p63b isoform. All p63 isoforms potentially bind to p53 responsive promoter elements but only TAp63g and TAp63b transactivate reporter genes at levels comparable with wild-type p53 (Celli et al, 1999) . TAp63a, possibly as consequence of an inhibitory effect of the C-terminus, and all p63DN isoforms completely lack this ability.
Basal keratinocytes in normal skin express detectable levels of DNp63a and its expression is associated with the proliferative potential in normal and neoplastic human keratinocytes (Parsa et al, 1999) . DNp63a overexpression in mouse epidermis using the loricrin promoter results neither in an overt phenotype nor in an altered proliferation rate (Liefer et al, 2000) .
Vitamin A and its major biologically active form all-trans retinoic acid have been appreciated as critical regulators of growth and differentiation in the developing and adult skin (Fisher and Voorhees, 1996) . Proliferating keratinocytes in the basal layer of the skin leave the cell cycle and move on to an early phase of differentiation. Subsequently, keratinocytes form cross-linked envelopes in a late stage of differentiation (Green and Watt, 1982) . Involucrin is a precursor protein of the corni®ed envelope and a marker for early keratinocyte differentiation.
In vitro, addition of retinoic acid to primary human keratinocyte cell cultures, which start to differentiate after growth factor withdrawal, ef®ciently retards corni®ed envelope formation and marginally stimulates proliferation. During the ®rst 14 d of retinoic acid supplementation the amount of involucrin is comparably high in treated and untreated keratinocyte cultures (Cline and Rice, 1983) , whereas the number of corni®ed envelopes is drastically reduced.
In vivo, retinoids do not suppress keratinocyte terminal differentiation but stimulate keratinocyte proliferation. Therefore, retinoic acid is thought to modify the ®nely tuned balance between these two cellular processes.
Because of the ability of retinoids to modify keratinocyte differentiation, we investigated p63 splice variant expression in human primary keratinocytes. As an experimental approach, we used cell cultures cultivated under differentiation promoting conditions (Poumay et al, 1999) to study the development of p63 expression in detail over time during terminal differentiation.
MATERIALS AND METHODS
Cell culture Normal human primary keratinocytes (Clonetics, CellSystems, St. Katharinen, Germany) were cultivated on cell culture plates (Nalge Nunc Int., Rochester, NY) at 37°C and 5% CO 2 . For all assays, keratinocytes in the third or fourth passage were used and media were renewed every second day. All experiments were repeated three times with different healthy donors for primary keratinocytes.
A simple change of culture media from proliferation-to differentiation-promoting cell culture conditions started the differentiation experiments. In detail, the proliferation-promoting keratinocyte growth medium (KGM-2, Clonetics) included bovine pituitary extract, insulin, transferrin, epinephrine, epidermal growth factor, and 0.15 mM CaCl 2 according to manufacturer's instructions. These supplements were omitted in the differentiation promoting keratinocyte basal medium-2 (Clonetics), whereas the calcium concentration was kept.
Keratinocytes at 50% cell density were washed twice with keratinocyte basal medium-2, cells were subsequently refed every second day with keratinocyte basal medium-2 and grown under differentiation promoting conditions for 11 d at 37°C and 5% CO 2 .
For retinoic acid treatment, keratinocytes grown to 50% cell density were washed twice with KGM-2 medium without bovine pituitary extract (KGM-2-BPE). Cells were cultivated for 10 further days at 37°C and 5% CO 2 in KGM-2-BPE supplemented with 0.1 mM all-trans retinoic acid (Sigma, Deisenhofen, Germany). Retinoic acid stock solutions were prepared in dimethyl sulfoxide (Sigma) and control cells were grown in KGM-2-BPE, including 0.01% dimethyl sulfoxide for the same time span.
HaCaT cells kindly provided by Dr. N. Fusenig (Boukamp et al, 1988) and HEK293 cells (Graham et al, 1977) were cultivated in DMEM (Gibco, Eggenstein, Germany), including 10% fetal bovine serum (Gibco).
Preparation of human epidermis Skin from circumcisions (kindly provided by the children's hospital, Universita Ètsklinikum-Hamburg Eppendorf) was washed three times in wash buffer (1 Q phosphatebuffered saline without calcium and magnesium supplemented with 0.5 mg per ml gentamicin (Gibco)); 0.25 cm 2 skin segments were dispase I digested (2.4 U per ml dispase I in wash buffer) overnight at 4°C. Using forceps, the epidermis was carefully separated from the dermis and stored at ±70°C.
RNA preparation Human tissues used for RNA isolation were removed at autopsy and stored at ±70°C. For RNA preparation from human cell culture cells, any liquid was removed from the Petri dishes, they were quickly cooled on dry ice and subsequently stored at ±70°C. Total RNA was isolated using RNAclean (Hybaid-AGS, Heidelberg, Germany) according to the manufacturer's instructions.
Northern blot, ribonuclease protection assay (RPA), and reverse transcription±polymerase chain reaction (reverse transcription± PCR) The northern blot technique was employed for quantitative detection of human mRNA with the following a-32 P-deoxycytidine triphosphate labeled cDNA fragments (Amersham, Freiburg, Germany). Labeling was carried out with the Prime it II Random Primer Labeling Kit (Stratagene, La Jolla, CA), cDNA fragments were puri®ed by gel ®ltration through Nuctrap Push columns (Stratagene) and quanti®ed in a Wallac 1409 scintillation counter (Wallac, Freiburg, Germany). The p63core probe of 232 bp length (nt 964±1195; GB: AF075430) was used to detect all human p63 mRNA splice variants. Involucrin expression was analyzed by a 1647 bp long involucrin cDNA fragment (nt 183± 1830; GB: M13902). The b-actin mRNA was identi®ed with a 377 bp long b-actin probe (nt 1418±2234, excluding intron C; GB: M10277). Glyoxal denatured total RNA (15 mg) was separated in a phosphatebuffered 1.2% agarose gel. The RNA was transferred overnight on to a Hybond-N nylon membrane (Amersham) according to the manufacturer's instructions. The RNA molecules were heat cross-linked to the nylon membrane (80°C, 2 h) and prehybridization was performed at 42°C in ULTRAhyb buffer (Ambion, Austin, TX) for 2 h. The denatured radioactive labeled cDNA probe (95°C, 10 min, followed by 4°C, 5 min) was added to ULTRAhyb buffer (preheated to 68°C) to a ®nal concentration of 2 Q 10 7 cpm per ml. The northern blot was incubated overnight at 42°C in hybridization buffer. After washing twice for 15 min at 42°C in 2 Q sodium citrate/chloride buffer/0.1% (wt/vol) sodium dodecyl sulfate (SDS) followed by 15 min at 42°C in 0.2 Q sodium citrate/chloride buffer/0.1% (wt/vol) SDS blots were analyzed with the phosphoimager system Fuji BAS-1800II reader and the AIDA software package (Raytest, Straubenhardt, Germany). The northern blot was stripped in 0.1 Q sodium citrate/chloride buffer/50% formamide (75°C, 1 h) and rehybridized with another radioactively labeled probe as described. Because of mRNA length and signal strength RNA were detected in the following order: p63, involucrin and b-actin.
For RPA, contaminating DNA in tissue and cell culture total RNA preparations was removed by DNaseI digestion (1 U per mg RNA, 15 min at 37°C in 1 Q transcription buffer; Roche, Mannheim, Germany). A total of 15 mg tissue RNA or 10 mg cell culture RNA per assay was incubated with 5 Q 10 5 cpm a-32 P-uridine triphosphate (Amersham) labeled probe at 42°C overnight in hybridization buffer (RPA-III-Kit, Ambion). A b-actin or hypoxanthine guanine phosphoribosyl transferase (HGPRT) speci®c probe (5 Q 10 4 cpm per total RNA probe) was included as internal control. Riboprobes have the suf®x``-p'' and were generated by in vitro transcription of 1 mg linearized plasmid DNA with T7 RNA polymerase (Roche). 5¢p63-p of 296 b length was used to hybridize to 236 b of the human p63TA mRNA (nt 166±401; GB: AF075430). Owing to the probe design (Fig 1) , simultaneous detection of p63DN was possible as a 195 b long protected complementary RNA fragment. The p63a and p63g splice variants were detected by the 3¢p63-p of 262 b length, resulting in protected complementary RNA fragments of 164 b and 201 b (nt 904±1104; GB: AF075429), respectively. A 335 b long HGPRT RNA fragment (nt 2324±568; GB: NM_000194) was protected by the 421 b long transcript named HGPRT-p. Act-p of 160 b length hybridized to 125 b of the human b-actin mRNA (nt 821±945; GB X00351; pTRI-b-actin-125-Human Anti-sense Control Template plasmid; Ambion; T3 RNA polymerase (Roche) transcript). For p63 5¢-end and 3¢-end detection, RNase treatment was carried out for 40 min at 37°C with RNaseA/T 1 (1:100 dilution) and RNaseT 1 (1:50 dilution; RPA-III-Kit; Ambion), respectively. After separation of complementary RNA fragments in a 8% polyacrylamide gel, radioactive bands were analyzed on the dried gel with the phosphoimager system Fuji BAS-1800II reader and the AIDA software package (Raytest).
For reverse transcription±PCR, 2 mg of total RNA was reverse transcribed using Superscript II reverse transcriptase (Gibco) and random hexamer primers (Amersham). A PCR approach with a p63 5¢-end forward and 3¢-end reverse oligonucleotide identi®ed the expressed p63 5¢/3¢-end combination. Speci®c p63 cDNA sequences were analyzed with the forward and reverse oligonucleotides listed in Table I . Primers were selected using the Lasergene program package (DNASTAR, Madison, WI). The HGPRT and one speci®c p63 splice variant cDNA were ampli®ed from 1/20 of the reverse transcribed total RNA with the ELONGASE Enzyme Mix (BRL Life Technologies). PCR was performed in 35 cycles (94°C for 2 min for the initial denaturation, 94°C for 30 s and 55°C for 30 s and 68°C for 2 min 30 s for each cycle and 68°C for 10 min for the ®nal elongation). PCR fragments were visualized with ethidium bromide after separation of equal volumes of each reaction on a 1.2% (wt/vol) agarose gel.
Western blot For SDS gel electrophoresis, cultured cells were lyzed in 1 Q gel-loading buffer (2% SDS/60 mM Tris (pH 7.5)/100 mM dithiothreitol). The proteins were heat denatured (96°C, 5 min) and Figure 1 . Schematic of the main p63 mRNA isotypes. Untranslated mRNA sequence is indicated in black. Gray areas highlight the conserved TA domain, the DNA binding domain (DBD), the oligomerization domain (OD) and the sterile a motif domain (SAM). Positions of the complementary RPA probes 5¢p63-p and 3¢p63-p are indicated.
after determination of protein concentration 10 mg per mm 2 protein was separated in a 8% SDS±acrylamide gel and blotted on to Immobilon-P (Millipore, Eschborn, Germany) according to standard procedures. Primary antibodies were diluted 1:200 for p63 monoclonal antibody 4A4 (Santa Cruz Biotechnology, Santa Cruz, CA), 1:10,000 for involucrin monoclonal antibody SY5 (Sigma) and 1 : 40,000 for b-actin monoclonal antibody 15 (Sigma) in blocking buffer (5% dried skimmed milk/1 Q Tris-buffered saline/0.2% Nonidet P-40). After incubation with primary antibody (4°C, o/n), blots were washed ®ve times in 1 Q Tris-buffered saline (room temperature, 10 min) and bound antibodies were detected with horseradish coupled anti-mouse IgG (dilution 1 : 2500 in blocking buffer, room temperature, 2 h, ECLSystem, Amersham). The ®nal washing was performed as described and the horseradish peroxidase activity was detected with the SuperSignal Substrate (Pierce, Rockford, IL), measured with a Lumi-Imager (Roche) and quanti®ed with the provided software.
RESULTS
Tissue distribution of p63 splice variants p63 expression was analyzed by RPA in different human tissues and cell lines with splice variant speci®c probes (Fig 1) . The RPA probe 5¢p63-p was used to detect p63TA (236 b). Protected complementary RNA fragments 41 b shorter than the expected p63TA fragment indicated p63DN (195 b) expression. In analogy, 3¢p63-p was designed for the two alternative p63 3¢-ends, p63a and p63g. 3¢p63-p protected 164 b common to all p63 splice variants and therefore indicated p63a and p63b expression. We did not differentiate between these isoforms because p63b is a minor transcript showing the same expression pro®le as p63a (Bamberger and Schmale, 2001 ). Additional 37 b are included in the case of p63g (201 b) expression. HGPRT expression was monitored as positive control in all tissues and cell lines.
As indicated by RPA analysis, the existence of all four investigated p63 splice variants DN, TA, a, and g was proven in human tongue consisting of multiple tissues such as epithelium, tongue muscle, and salivary glands (Fig 2A, B) . RPA detected weakly but consistently the existence of TAp63g mRNA in human skeletal muscle tissue. Very weak expression of p63DN was also found in skeletal muscle. The same RPA experiments suggest DNp63a expression in human placenta. In a spontaneously transformed human epithelial cell line from adult skin termed HaCaT (Boukamp et al, 1988) DNp63a was detectable in 25% higher levels than in proliferating primary human keratinocytes when normalized to HGPRT expression. As a negative control, the human embryonic kidney cell line HEK293 (Graham et al, 1977) was included in a 5-fold excess of total RNA. Neither 5¢p63-p nor 3¢p63-p detected any p63 expression.
p63 expression in human keratinocytes The described RPA experiments demonstrated the tissue distribution of individual p63 splice modules. Proliferating human primary keratinocytes in cell culture expressed DNp63a as the major splice variant. In order to investigate the p63 expression in human keratinocytes in more detail, speci®c PCR primers were used to amplify the entire coding region. In normal human epidermal total RNA, DNp63a was veri®ed as the major p63 splice variant (Fig 3A) . In addition, very weak expression of TAp63a and DNp63g was detected. Southern blot analysis of 1/50 of the reverse transcription±PCR reaction volume veri®ed the TA1p63a and TA2p63a expression in the human epithelium (not shown). TA1 and TA2 represent two alternative 5¢-ends of the TA containing isoforms (Bamberger and Schmale, 2001 ). Reverse transcription±PCR experiments did not show comparable expression intensity of TAp63a in normal human primary keratinocytes, whereas DNp63a and DNp63g expression was still observed (Fig 3B) . Nonquantitative reverse transcription±PCR results suggest a ratio of DNp63b to DNp63a of 1:10. HGPRT ampli®cation was included in the same reverse transcription±PCR reaction as positive control in both experiments. In order to demonstrate successful PCR of the p63 variants, about 10,000 cDNA copies of every splice variant served as the template in a positive PCR reaction (Fig 3C) . Ampli®cation failed in a negative control reaction (not shown).
p63 expression during keratinocyte differentiation One major question concerning p63 in skin is its change in expression during early differentiation of epidermal keratinocytes. We followed p63 expression in keratinocytes grown under differentiation promoting conditions with emphasis on the quantity and the pattern of the observed p63 splice variants. Northern blot analysis indicated a 5-fold reduction in the DNp63a mRNA level after 11 d of culture under differentiation promoting conditions when normalized to b-actin (Fig 4A) . The process of ongoing differentiation of the keratinocytes was shown by the 4-fold induction of the involucrin mRNA expression, used as a positive marker for early differentiation. The observed reduction of DNp63a mRNA results in a 50-fold decrease in protein as shown by western blot analysis (Fig 4B) . In addition, RPA experiments indicated no upregulation of any of the two other p63 splice variants TA and g at the time points investigated (Fig 4C, D) . A second protein detected by the monoclonal 4A4 antibody, which migrates faster than the 61 kDa marker protein, might result from the translation of DNp63g mRNA because very weak expression of the g isoform was also detected with RPA ( Fig 4D) . The change in p63 mRNA expression relative to b-actin expression was quanti®ed in three independent experiments using RPA (Fig 4E) .
The in¯uence of retinoic acid on p63 expression Addition of retinoic acid to the cell culture medium prevents terminal differentiation of human primary keratinocytes. When compared with control cell cultures, p63 mRNA and protein levels remained high in keratinocytes after 10 d of treatment with 0.1 mM all-trans retinoic acid (Fig 5) . Northern blot analysis (Fig 5A) and western blot analysis (Fig 5B) indicated high expression of both DNp63a mRNA and protein. RPA investigations veri®ed these results and further indicated unchanged expression of the two other p63 splice variants TA and g (Fig 5C, D) . Upregulation of involucrin mRNA and protein was not in¯uenced by retinoic acid (Green and Watt, 1982) . The corni®ed envelope assay (Rice and Green, 1979) indicated incomplete differentiation of retinoic acid treated keratinocytes as expected (not shown). The expression of DNp63a in the presence of retinoic acid was constant when studied at different time points (Fig 5E) . In the keratinocyte control culture DNp63a was downregulated during the process of differentiation.
DISCUSSION
Expression of a predominant p63 splice variant might be characteristic for a speci®c cell type. In a proliferating keratinocyte primary cell culture DNp63a is the major isoform found. In contrast, TAp63g is the isoform predominantly observed in skeletal muscle. Different tissue components might contribute to the detection of all major p63 isoforms in the human tongue; however, the p63 positive cell types in tongue and placenta were not determined.
Very low expression of TAp63a was observed in normal human epidermis. Nonquantitative reverse transcription±PCR results suggest a reduction in TAp63a expression in keratinocytes upon in vitro cultivation. Interestingly, TAp63a was detected in HaCaT cells on protein level and in SCC25 cells by reverse transcription±PCR . Expression of TAp63a is the major difference between epidermis and cultured epidermal keratinocytes. Although contamination of the human epidermis with another cell type expressing this p63 isoform cannot be excluded, these data might imply that TAp63a is the critical splice variant for the long-term survival of keratinocytes. Alternatively, the existence of both minor expressed splice variants, TAp63a and DNp63g, might be explained by leaky transcription and accidental splicing events.
In the cell culture model used here, keratinocytes began to differentiate and started to express the early differentiation marker involucrin. We showed a reduction in DNp63a expression in primary human keratinocyte cell culture when cells escaped from the cell cycle and started to differentiate. In situ hybridization and immunohistochemistry revealed high p63 expression only in the basal layer, the proliferative compartment of the skin (Parsa et al, 1999) . This expression pro®le correlates with the high p63 expression observed in the proliferating keratinocyte cell culture and subsequent downregulation during differentiation. The change in DNp63a expression is in agreement with the previously reported cell size dependent expression of DNp63a (Parsa et al, 1999) . Parsa et al (1999) found that small keratinocytes with high colony forming potential expressed high amounts of DNp63a, whereas large differentiated keratinocytes showed only marginal expression. In accordance with our results, normal human epidermal keratinocytes induced to differentiate in vitro by high calcium exposure downregulated all p63 isoforms (De Laurenzi et al, 2000) . Results obtained by different experimental paradigms ± the p63 downregulation after calcium induced differentiation (De Laurenzi et al, 2000) , the cell size dependent expression observed by Parsa et al (1999) and the differentiation time dependent expression Figure 5 . Retinoic acid blocks the DNp63a reduction observed during differentiation of human primary keratinocytes. After 10 d exposure to 0.1 mM retinoic acid, northern blot (A) and western blot (B) assays indicated continuous DNp63a expression in comparison with untreated keratinocytes. The splice variant expression was investigated with RPA for different p63 5¢-ends (C) and 3¢-ends (D). The development of DNp63a expression during cultivation in control and retinoic acid treated human primary keratinocytes was monitored on protein level using the western blot technique (E). Phase-contrast photographs indicate the morphologic changes of human primary keratinocytes after 11 d of culture with or without retinoic acid (F). Scale bar: 50 mm.
described here ± argue for high DNp63a levels in proliferating keratinocytes and a downregulation during differentiation. No change in the relative p63 splice variant pattern was observed at the investigated time points. Whether the p63 expression changes its pattern in keratinocytes in the early response phase to growth factor withdrawal was not investigated.
Retinoic acid added to a keratinocyte cell culture is known to inhibit the expression of the differentiated phenotype (Fisher and Voorhees, 1996) . Retinoids allow keratinocytes to proceed through the early steps of differentiation but block the subsequent corni®ed envelope formation (Green and Watt, 1982) . In vivo, retinoic acid stimulates in the skin the division of the basal keratinocytes that migrate upward and differentiate (Fisher et al, 1991) . Sustained expression of DNp63a in retinoic acid treated keratinocytes argues for this p63 isoform as a marker for the keratinocyte proliferation capacity. In addition, other signals provided in the basal compartment of normal human epidermis may be needed for keratinocytes in order to proceed through the cell cycle.
Is downregulation of DNp63a essential for the onset of differentiation or rather required to allow other processes that are speci®c for the differentiated phenotype in suprabasal layers of the epidermis? Transgenic mice overexpressing DNp63a in the skin under the control of the basal loricrin promoter show unaltered proliferation and differentiation of keratinocytes (Liefer et al, 2000) . This ®nding and our data suggest that DNp63a downregulation is not the driving force for differentiation. Absence of the dominantnegative DNp63a isoform may release speci®c DNA-binding sites in responsive genes and allow transcriptional activity of p53 and p73, the other members of the p53 family.
Despite a decrease in p53 mRNA and protein in human keratinocytes during differentiation, p53-mediated transcription activity increases (Weinberg et al, 1995) . The downregulation of the dominant negative DNp63a isoform might explain the observed increase of p53 activity because both proteins may compete for the same responsive elements in target gene promoters. Recently it has been shown that downregulation of p63 is required for epidermal Ultraviolet B induced p53-dependent apoptosis (Liefer et al, 2000) . Along these lines, the transcriptionally active isoform of p73, TAp73d, is induced in keratinocytes exposed to high calcium, whereas the expression of DNp63a is decreased. TAp73d was reported to be effective in inducing transactivation of the epidermal differentiation markers, involucrin and loricrin (De Laurenzi et al, 2000) . p53-and p73-null mice, however, exhibit histologically normal skin suggesting a highly redundant and complex regulatory protein network for keratinocyte differentiation.
Vitamin A de®ciency and loss of p63 result in malformation of distal limb structures. Mice without a functional p63 gene show major defects in their limb, craniofacial, and epithelial development (Mills et al, 1999; Yang et al, 1999) . Their hindlimbs are absent and the forelimbs are truncated because the apical ectodermal ridge, an epithelium essential for limb development, is not maintained. Interestingly, vitamin A de®ciency during early mammalian development results in malformations that include cleft face, palate, and lip, and abnormalities of the forelimbs (Morriss-Kay and Ward, 1999) . A similar phenotype is caused by heterozygous germline mutations in p63 observed in patients who exhibit a syndrome of ectrodactyly, ectodermal dysplasia and cleft lip with or without cleft palate (Celli et al, 1999) . Hence p63 expression maintained by retinoic acid seems to be necessary for normal limb development.
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